{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:16:01Z","timestamp":1790043361247,"version":"4.0.1"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Tissue Res"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00441-022-03609-w","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T04:03:02Z","timestamp":1646712182000},"page":"211-223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Yeast red pigment, protein aggregates, and amyloidoses: a review"],"prefix":"10.1007","volume":"388","author":[{"given":"Olga V.","family":"Nevzglyadova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina V.","family":"Mikhailova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4424-2995","authenticated-orcid":false,"given":"Tonu R.","family":"Soidla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"key":"3609_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4161\/pri.22470","volume":"6","author":"S Alberti","year":"2012","unstructured":"Alberti S (2012) Molecular mechanisms of spatial protein quality control. Prion 6:437\u2013442","journal-title":"Prion"},{"key":"3609_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1134\/S1990519X13010021","volume":"7","author":"TR Amen","year":"2013","unstructured":"Amen TR, Mikhailova EV, Alenin VV, Artyomov AV, Dementyev PA, Khodorkovskii MA, Artamonova TO, Kuznetsova IM, Soidla TR, Nevzglyadova OV (2013) Structural and functional characteristics of various forms of red pigment of yeast Saccharomyces cerevisiae and its synthetic analog. Cell Tissue Biol 7:86\u201394","journal-title":"Cell Tissue Biol"},{"key":"3609_CR3","volume-title":"Budding yeast: a laboratory manual","author":"B Andrews","year":"2016","unstructured":"Andrews B, Boone C, Davis TN, Fields F (2016) Budding yeast: a laboratory manual. Cold Spring Harbor laboratory Press, NY"},{"key":"3609_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-015-1514-0","volume":"131","author":"JI Ayers","year":"2016","unstructured":"Ayers JI, Fromholt SE, O\u2019Neal VM, Diamond JH, Borchelt DR (2016) Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways. Acta Neuropathol 131:103\u2013114","journal-title":"Acta Neuropathol"},{"issue":"4","key":"3609_CR5","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanovski JQ, Iwatsubo T (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am J Pathology 152(4):879\u2013890","journal-title":"Am J Pathology"},{"key":"3609_CR6","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1091\/mbc.e08-01-0078","volume":"19","author":"SN Bagriantsev","year":"2008","unstructured":"Bagriantsev SN, Gracheva EO, Richmond JE, Liebman SW (2008) Variant-specific [PSI+] infection Istransmitted by Sup35 polymers within [PSI+] aggregates with heterogeneous protein composition. Mol Biol Cell 19:2433\u20132443","journal-title":"Mol Biol Cell"},{"key":"3609_CR7","doi-asserted-by":"crossref","unstructured":"Banci L, Bertini I, Boca M, Girotto S, Martinelli M, Valentine JS, Vieru M (2008) SOD1 and amyotrophic lateral sclerosis: mutations and oligomerization. PloS One 3:e1677","DOI":"10.1371\/journal.pone.0001677"},{"key":"3609_CR8","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.euroneuro.2013.03.007","volume":"25","author":"TA Bayer","year":"2015","unstructured":"Bayer TA (2015) Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders? Eur Neuropsychopharmacol 25:713\u2013724","journal-title":"Eur Neuropsychopharmacol"},{"key":"3609_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova I, Karran E, DeStooper B (2012) The toxic Ab oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat Neurosci 15:349\u2013357","journal-title":"Nat Neurosci"},{"key":"3609_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/bs.pmbts.2019.07.010","volume":"168","author":"G Bitan","year":"2019","unstructured":"Bitan G (2019) Disease-modifying therapy for proteinopathies: can the exception become the rule? Prog Mol Biol Transl Sci 168:277\u2013287","journal-title":"Prog Mol Biol Transl Sci"},{"key":"3609_CR11","first-page":"3055","volume":"21","author":"H Bolus","year":"2020","unstructured":"Bolus H, Crocker K, Boekho-Falk G, Chtarbanova S (2020) Modeling neurodegenerative disorders in Drosophila melanogaster. Int J Mol Sci 21:3055","journal-title":"Int J MolSci"},{"issue":"8","key":"3609_CR12","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.3390\/ijms19082292","volume":"19","author":"SA Bondarev","year":"2018","unstructured":"Bondarev SA, Antonets KS, Kajava AV, Nizhnikov AA, Zhouravleva GA (2018) Protein co-aggregation related to amyloids: methods of investigation, diversity, and classification. Int J Mol Sci 19(8):2292","journal-title":"Int J Mol Sci"},{"key":"3609_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1534\/genetics.111.130765","volume":"189","author":"D Botstein","year":"2011","unstructured":"Botstein D, Fink GR (2011) Yeast: an experimental organism for 21st century biology. Genetics 189:695\u2013704","journal-title":"Genetics"},{"issue":"4","key":"3609_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/jnc.14965","volume":"153","author":"DMA Br\u00e1s IC","year":"2020","unstructured":"Br\u00e1s IC, Domingues-Meijide A, Gerhardt E, Koss D, L\u00e1zaro DF, Santos PI, Vasili E, Xylaki M, Outeiro TF (2020) Synucleinopathies: where we are and where we need to go. J Neurochem 153(4):433\u2013454","journal-title":"J Neurochem"},{"key":"3609_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cell.2006.04.014","volume":"125","author":"B Bukau","year":"2006","unstructured":"Bukau B, Weissman J, Horwich A (2006) Molecular chaperones and protein quality control. Cell 125:443\u2013451","journal-title":"Cell"},{"key":"3609_CR16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3389\/fnins.2019.00659","volume":"13","author":"XQ Chen","year":"2019","unstructured":"Chen XQ, Mobley WC (2019) Share Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric A\u03b2 and Tau species. Front Neurosci 13:659","journal-title":"Front Neurosci"},{"key":"3609_CR17","unstructured":"Chernoff YO (2004) Cellular control of prion formation and propagation in yeast. In: Telling GC (ed) Prions and prion diseases: current perspectives. Horizon Bioscience: Wymondham pp 257\u2013303"},{"key":"3609_CR18","doi-asserted-by":"crossref","unstructured":"Chernoff YO, Grizel AV, Rubel AA, Zelinsky AA, Chandramowlishwaran P, Chernova TA (2020) Application of yeast to studying amyloid and prion diseases. In: Kumar D (ed) Advances in Genetics. Volume 105 Academic Press Elsevier Inc pp 293\u2013380","DOI":"10.1016\/bs.adgen.2020.01.002"},{"key":"3609_CR19","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1126\/science.7754373","volume":"268","author":"YO Chernoff","year":"1995","unstructured":"Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW (1995) Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [PSI+]. Science 268:880\u2013884","journal-title":"Science"},{"issue":"2","key":"3609_CR20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/1574-6976.12053","volume":"38","author":"TA Chernova","year":"2014","unstructured":"Chernova TA, Wilkinson KD, Chernoff YO (2014) Physiological and environmental control of yeast prions. FEMS Microbiol Rev 38(2):326\u2013344","journal-title":"FEMS Microbiol Rev"},{"key":"3609_CR21","doi-asserted-by":"crossref","unstructured":"Chernova TA, Wilkinson KD, Chernoff YO (2017) Prions, chaperones, and proteostasis in yeast.Cold Spring Harbor Perspectives in Biology 9(2):a023663","DOI":"10.1101\/cshperspect.a023663"},{"key":"3609_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejphar.2017.05.057","volume":"817","author":"A Copani","year":"2017","unstructured":"Copani A (2017) The underexplored question of \u03b2-amyloid monomers. Eur J Pharmacol 817:71\u201375","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"3609_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4161\/pri.1.3.4839","volume":"1","author":"BS Cox","year":"2007","unstructured":"Cox BS, Byrne LJ, Tuite MF (2007) Prion stability. Prion 1(3):170\u2013178","journal-title":"Prion"},{"key":"3609_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nsb935","volume":"10","author":"JS Elam","year":"2003","unstructured":"Elam JS, Taylor AB, Strange R, Antonyuk S, Doucette PA, Rodriguez JA, Hasnain SS, Hayward LJ, Valentine JS, Yeates TO, Hart PJ (2003) Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat Struct Biol 10:461\u2013467","journal-title":"Nat Struct Biol"},{"key":"3609_CR25","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1101\/gad.439307","volume":"21","author":"N Erjavec","year":"2007","unstructured":"Erjavec N, Larsson L, Grantham J, Nystrom T (2007) Accelerated aging and failure to segregate damaged proteins in Sir2 mutants can be suppressed by overproducing the protein aggregation remodeling factor Hsp104p. Genes Dev 21:2410\u20132421","journal-title":"Genes Dev"},{"key":"3609_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.bbapap.2014.11.005","volume":"1854","author":"SG Est\u00e1cio","year":"2015","unstructured":"Est\u00e1cio SG, Leal SS, Crist\u00f3v\u00e3o JS, Fa\u00edsca PF, Gomes CM (2015) Calcium binding to gatekeeper residues flanking aggregation-prone segments underlies nonfibrillar amyloid traits in superoxide dismutase 1 (SOD1). Biochim Biophys Acta 1854:118\u2013126","journal-title":"Biochim Biophys Acta"},{"key":"3609_CR27","doi-asserted-by":"crossref","unstructured":"Feany B, Bender W (2000) A Drosophila model of Parkinson\u2019s disease. Nature 404:394\u2013398","DOI":"10.1038\/35006074"},{"key":"3609_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/0006-291X(69)90832-8","volume":"34","author":"CR Fisher","year":"1969","unstructured":"Fisher CR (1969) Enzymology of the pigmented adenine-requiring mutants of Saccharomyces and Schizosaccharomyces. Biochem Biophys Res Commun 34:306\u2013310","journal-title":"Biochem Biophys Res Commun"},{"key":"3609_CR29","doi-asserted-by":"crossref","unstructured":"\u00a0Franssens V, Boelen E, Anandhakumar J, Vanhelmont T, B\u00fcttner S, Winderickx J (2010) Yeastunfolds the road map toward \u03b1-synuclein-induced cell death. Cell Death Diff 17(5):746\u2013753","DOI":"10.1038\/cdd.2009.203"},{"key":"3609_CR30","doi-asserted-by":"publisher","first-page":"6533","DOI":"10.1038\/ncomms7533","volume":"6","author":"I Gallina","year":"2015","unstructured":"Gallina I, Colding C, Henriksen P, Beli P, Nakamura K, Offman J, Mathiasen DP, Silva S, Hoffmann E, Groth A, Choudhary C, Lisby M (2015) Cmr1\/WDR76 defines a nuclear genotoxic stress body linking genome integrity and protein quality control. Nat Commun 6:6533","journal-title":"Nat Commun"},{"key":"3609_CR31","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"16","author":"G Glenner","year":"1984","unstructured":"Glenner G, Wong C (1984) Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 16:885\u2013890","journal-title":"Biochem Biophys Res Commun"},{"key":"3609_CR32","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1471-4159.2007.04988.x","volume":"104","author":"FJ Gonzalez-Velasquez","year":"2008","unstructured":"Gonzalez-Velasquez FJ, Moss MA (2008) Soluble aggregates of the amyloid-b protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells. J Neurochem 104:500\u2013551","journal-title":"J Neurochem"},{"key":"3609_CR33","doi-asserted-by":"crossref","unstructured":"Grousl T, Ungelenk S, Miller S, Ho CT, Khokhrina M, Mayer MP, Bukau B, Mogk A (2018) A prion-like domain in Hsp42 drives chaperone-facilitated aggregation of misfolded proteins. J Cell Biolpii jcb.201708116","DOI":"10.1083\/jcb.201708116"},{"key":"3609_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"T Guo","year":"2020","unstructured":"Guo T, Zhang D, Zeng Y, Huang TX, Xu H, Zhao Y (2020) Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol Neurodegeneration 15:40","journal-title":"Mol Neurodegeneration"},{"issue":"5","key":"3609_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.tips.2013.03.002","volume":"34","author":"F Hefti","year":"2013","unstructured":"Hefti F, Goure WF, Jerecic J, Iverson KS, Walicke PA, Krafft GA (2013) The case for soluble A\u03b2 oligomers as a drug target in Alzheimer\u2019s disease. Trends PharmacolSci 34(5):261\u2013266","journal-title":"Trends PharmacolSci"},{"key":"3609_CR36","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1263\/jbb.99.437","volume":"99","author":"K Irie","year":"2005","unstructured":"Irie K, Murakami K, Masuda Y, Morimoto A, Ohigashi H, Ohashi R, Takegoshi K, Nagao M, Shimizu T, Shirasawa T (2005) Structure of beta-amyloid fibrils and its relevance to their neurotoxicity: implications for the pathogenesis of Alzheimer\u2019s disease. J Biosci Bioeng 99:437\u2013447","journal-title":"J Biosci Bioeng"},{"issue":"1","key":"3609_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","volume":"13","author":"T Iwatsubo","year":"1994","unstructured":"Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13(1):45\u201353","journal-title":"Neuron"},{"issue":"7","key":"3609_CR38","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1083\/jcb.143.7.1883","volume":"143","author":"JA Johnston","year":"1998","unstructured":"Johnston JA, Ward CL, Kopito RR (1998) Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143(7):1883\u20131898","journal-title":"J Cell Biol"},{"key":"3609_CR39","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/nature07195","volume":"454","author":"D Kaganovich","year":"2008","unstructured":"Kaganovich D, Kopito R, Frydman J (2008) Misfolded proteins partition between two distinct quality control compartments. Nature 454:1088\u20131095","journal-title":"Nature"},{"key":"3609_CR40","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0076-6879(06)13017-7","volume":"413","author":"R Kayed","year":"2006","unstructured":"Kayed R, Glabe C (2006) Conformation-dependent anti amyloid oligomer antibodies. Methods Enzymol 413:326\u2013344","journal-title":"Methods Enzymol"},{"issue":"12","key":"3609_CR41","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0962-8924(00)01852-3","volume":"10","author":"RR Kopito","year":"2000","unstructured":"Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation. Trends in Cell Biol 10(12):524\u2013530","journal-title":"Trends in Cell Biol"},{"issue":"14","key":"3609_CR42","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.12998\/wjcc.v7.i14.1764","volume":"7","author":"E Koseoglu","year":"2019","unstructured":"Koseoglu E (2019) New treatment modalities in Alzheimer\u2019s disease. World J Clin Cases 7(14):1764\u20131774","journal-title":"World J Clin Cases"},{"key":"3609_CR43","doi-asserted-by":"publisher","first-page":"49636","DOI":"10.1074\/jbc.M307996200","volume":"278","author":"DS Kryndushkin","year":"2003","unstructured":"Kryndushkin DS, Alexandrov IM, Ter-Avanesyan MD, Kushnirov VV (2003) Yeast [PSI +] protein aggregates are formed by small Sup35 polymers fragmented by Hsp104. J Biol Chem 278:49636\u201349643","journal-title":"J Biol Chem"},{"key":"3609_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2202-8-54","volume":"8","author":"T Kukar","year":"2007","unstructured":"Kukar T, Prescott S, Eriksen JL, Holloway V, Murphy MP, Koo EH, Golde TE, Nicolle MM (2007) Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice. BMC Neurosci 8:54","journal-title":"BMC Neurosci"},{"key":"3609_CR45","doi-asserted-by":"crossref","unstructured":"Kushnirov VV, Vishnevskaya AB, Alexandrov AM, Ter-Avanesyan MD (2007) Prion and nonprion amyloids: a comparison inspired by the yeast Sup35 protein. In: Chernoff YO (ed) Protein based inheritance. Landes Bioscience: Austin, TX pp 73\u201382","DOI":"10.4161\/pri.1.3.4840"},{"key":"3609_CR46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1534\/genetics.109.110213","volume":"184","author":"AK Lancaster","year":"2010","unstructured":"Lancaster AK, Bardill JP, True HL, Masel J (2010) The spontaneous appearance rate of the yeast prion [PSI+] and its implications for the evolution of the evolvability properties of the [PSI+] system. Genetics 184:393\u2013400","journal-title":"Genetics"},{"issue":"1","key":"3609_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA, Hardy J, Schott JM (2018) Alzheimer\u2019s disease. Eur J Neurol 25(1):59\u201370","journal-title":"Eur J Neurol"},{"key":"3609_CR48","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/14756360802048939","volume":"24","author":"Y Laras","year":"2009","unstructured":"Laras Y, Garino C, Dessolin J, Weck C, Moret V, Rolland A, Kraus JL (2009) New N(4)-substituted piperazinenaphthamide derivatives as BACE-1 inhibitors. J Enzyme Inhib Med Chem 24:181\u2013187","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3609_CR49","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fnmol.2020.00098","volume":"13","author":"R Malik","year":"2020","unstructured":"Malik R, Wiedau M (2020) Therapeutic approaches targeting protein aggregation in amyotrophic lateral sclerosis. Front Mol Neurosci 13:98","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"3609_CR50","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrn1199","volume":"4","author":"E Maries","year":"2003","unstructured":"Maries E, Dass B, Collier TJ, Kordower JH, Steece-Collier K (2003) The role of alpha-synuclein in Parkinson\u2019s disease: insights from animal models. Nat Rev Neurosci 4(9):727\u2013738","journal-title":"Nat Rev Neurosci"},{"key":"3609_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neuron.2006.09.025","volume":"52","author":"JL Marsh","year":"2006","unstructured":"Marsh JL, Michels L (2006) Drosophila in the study review of neurodegenerative disease. Neuron 52:169\u2013178","journal-title":"Neuron"},{"issue":"13","key":"3609_CR52","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.1073\/pnas.1102762108","volume":"108","author":"RP McGlinchey","year":"2011","unstructured":"McGlinchey RP, Kryndushkin D, Wickner RB (2011) Suicidal [PSI+] is a lethal yeast prion. Proc Natl Acad Sci USA 108(13):5337\u20135341","journal-title":"Proc Natl Acad Sci USA"},{"key":"3609_CR53","doi-asserted-by":"crossref","unstructured":"Meldolesi J (2019) Alzheimer\u2019s disease: key developments support promising perspectives fortherapy. Pharmacol Res 146:104316","DOI":"10.1016\/j.phrs.2019.104316"},{"key":"3609_CR54","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/0014-5793(85)80344-6","volume":"182","author":"A Meskauskas","year":"1985","unstructured":"Meskauskas A, Ksenzenko V, Shlyapnikov M, Kryukov V, Citavicius D (1985) \u2018Red pigment\u2019 from ADE-2 mutants of S. cerevisiae prevents DNA cleavage by restriction endonucleases. FEBS Lett 182:413\u2013414","journal-title":"FEBS Lett"},{"issue":"6","key":"3609_CR55","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1134\/S1990519X11060095","volume":"5","author":"EV Mikhailova","year":"2011","unstructured":"Mikhailova EV, Artemov AV, Snigirevskaya ES, Artamonova TO, Khodorkovskii MA, Soidla TR, Nevzglyadova OV (2011) The effect of red pigment on insulin fibril formation in vitro. Cell Tissue Biol 5(6):580\u2013585","journal-title":"Cell Tissue Biol"},{"key":"3609_CR56","first-page":"325","volume":"3","author":"SB Miller","year":"2008","unstructured":"Miller-Fleming L, Giorgini F, Outeiro TF (2008) Yeast as a model for studying human neurodegenerative disorders. Biotechnology J 3(3):325\u2013338","journal-title":"<div class=\"NodiCopyInline\">Biotechnology<\/div>"},{"key":"3609_CR57","doi-asserted-by":"publisher","first-page":"778","DOI":"10.15252\/embj.201489524","volume":"34","author":"SB Miller","year":"2015","unstructured":"Miller SB, Ho CT, Winkler J, Khokhrina M, Neuner A, Mohamed MY, Guilbride DL, Richter K, Lisby M, Schiebel E, Mogk A, Bukau B (2015) Compartment-specific aggregases direct distinct nuclear and cytoplasmic aggregate deposition. EMBO J 34:778\u2013797","journal-title":"<div class=\"NodiCopyInline\">EMBO J<\/div>"},{"key":"3609_CR58","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s11055-017-0427-x","volume":"47","author":"VN Mukhin","year":"2017","unstructured":"Mukhin VN, Pavlov KI, Klimenko VM (2017) Mechanisms of neuron loss in Alzheimer\u2019s disease. Neurosci Behav Phys 47:508\u2013516","journal-title":"Neurosci Behav Phys"},{"issue":"9","key":"3609_CR59","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1073\/pnas.1017275108","volume":"108","author":"OJ Munch","year":"2011","unstructured":"Munch OJ, O'Brien J, Bertolotti A (2011) Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci USA 108(9):3548\u20133553","journal-title":"Proc Natl Acad Sci USA"},{"key":"3609_CR60","doi-asserted-by":"crossref","unstructured":"Needham PG, Guerriero CJ, Brodsky JL (2019) Chaperoning endoplasmic reticulum\u2013associated degradation (ERAD) and protein conformational diseases. Cold Spring Harb Perspect Biol 11:a033928","DOI":"10.1101\/cshperspect.a033928"},{"key":"3609_CR61","doi-asserted-by":"crossref","unstructured":"Nevzglyadova OV, Artemov AV, Mittenberg AG, Kostyleva EI, Mikhailova EV, Solovev KV, Kuznetsova IM, Turoverov KK, Soidla TR (2010a) Comparison of crude lysate pellets of isogenic strains of yeast with different prion composition: Identification of prion-associated proteins. Cell Tissue Biol 4(1):36\u201345","DOI":"10.1134\/S1990519X10010049"},{"key":"3609_CR62","doi-asserted-by":"crossref","unstructured":"Nevzglyadova OV, Artemov AV, Mittenberg AG, Mikhailova EV, Kuznetsova IM, Turoverov KK, Soidla TR (2010b) The effect of red pigment on amyloidization of yeast proteins. Cell Tissue Biol 4(2):152\u2013166","DOI":"10.1134\/S1990519X10020057"},{"issue":"11","key":"3609_CR63","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/yea.1710","volume":"26","author":"OV Nevzglyadova","year":"2009","unstructured":"Nevzglyadova OV, Artemov AV, Mittenberg AG, Solovyov KV, Kostyleva EI, Mikhailova EV, Kuznetsova IM, Turoverov KK, Soidla TR (2009) Prion-associated proteins in yeast: comparative analysis of isogenic [PSI+] and [psi-] strains. Yeast 26(11):611\u2013631","journal-title":"Yeast"},{"issue":"1","key":"3609_CR64","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1134\/S1990519X08010112","volume":"2","author":"OV Nevzglyadova","year":"2008","unstructured":"Nevzglyadova OV, Kuznetsova IM, Artemov AV, Mikhailova EV, Turoverov KK, Soidla TR (2008) Comparative assay of amyloid and prion contents in yeast cells. Cell Tissue Biol 2(1):71\u201380","journal-title":"Cell Tissue Biol"},{"issue":"7","key":"3609_CR65","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/yea.1854","volume":"28","author":"KIM NevzglyadovaOV","year":"2011","unstructured":"Nevzglyadova OV, Kuznetsova IM, Mikhailova EV, Artamonova TO, Artemov AV, Mittenberg AG, Kostyleva EI, Turoverov KK, Khodorkovskii MA, Soidla TR (2011) The effect of red pigment on amyloidization of yeast proteins. Yeast 28(7):505\u2013526","journal-title":"Yeast"},{"issue":"2","key":"3609_CR66","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3109\/13506129.2015.1010038","volume":"22","author":"OV Nevzglyadova","year":"2015","unstructured":"Nevzglyadova OV, Mikhailova EV, Amen TR, Zenin VV, Artemov AV, Kostyleva EI, Mezhenskaya DA, Rodin DI, Saifitdinova AF, Khodorkovskii MA, Sarantseva SV, Soidla TR (2015) Yeast red pigment modifies Amyloid beta growth in Alzheimer disease models in both Saccharomyces cerevisiae and Drosophila melanogaster. Amyloid 22(2):100\u2013111","journal-title":"Amyloid"},{"key":"3609_CR67","unstructured":"Nevzglyadova OV, Mikhailova EV, Artemov AV, Mittenberg AG, Kuznetsova IM, Turoverov KK, Khodorkovskii MA, Soidla TR (2012) Chapter 1. The effect of yeast red pigment on amyloid fibrils in vivo and in vitro. In: Halcheck IP and Vernon NR (eds) Amyloids: Composition, Functions and Pathology. Nova Science Publishers: Hauppauge, NY, USA 1\u201332"},{"key":"3609_CR68","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neuint.2018.08.002","volume":"120","author":"OV Nevzglyadova","year":"2018","unstructured":"Nevzglyadova OV, Mikhailova EV, Artemov AV, Ozerova YE, Ivanova PA, Golomidov IM, Bolshakova OI, Zenin VV, Kostyleva EI, Soidla TR, Sarantseva SV (2018) Yeast red pigment modifies cloned human \u03b1-synuclein pathogenesis in Parkinson disease models in Saccharomyces cerevisiae and Drosophila melanogaster. Neurochem Int 120:172\u2013181","journal-title":"Neurochem Int"},{"issue":"S1","key":"3609_CR69","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/jnc.13750","volume":"139","author":"W Oertel","year":"2016","unstructured":"Oertel W, Schulz JB (2016) Current and experimental treatments of Parkinson disease: a guide for neuroscientists. J Neurochem 139(S1):325\u2013337","journal-title":"J Neurochem"},{"key":"3609_CR70","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.1090439","volume":"302","author":"TF Outeiro","year":"2003","unstructured":"Outeiro TF, Lindquist S (2003) Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302:1772\u20131775","journal-title":"Science"},{"key":"3609_CR71","doi-asserted-by":"crossref","unstructured":"Outeiro TF, Mestre TA (2019) Synuclein meeting 2019: where we are and where we need to go. J Neurochem 150(5):462\u2013466","DOI":"10.1111\/jnc.14825"},{"issue":"23","key":"3609_CR72","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB (1998) Prions Proc Natl Acad Sci USA 95(23):13363\u201313383","journal-title":"Prions Proc Natl AcadSci USA"},{"issue":"2","key":"3609_CR73","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1212\/WNL.0000000000001739","volume":"85","author":"BA Racette","year":"2015","unstructured":"Racette BA, Willis AW (2015) Time to change the blind men and the elephant approach to Parkinson disease? Neurology 85(2):190\u2013196","journal-title":"Neurology"},{"issue":"10","key":"3609_CR74","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1091\/mbc.e06-05-0475","volume":"17","author":"GF Ribeiro","year":"2006","unstructured":"Ribeiro GF, C\u00f4rte-Real M, Johansson B (2006) Characterization of DNA damage in yeast apoptosis induced by hydrogen peroxide, acetic acid, and hyperosmotic shock. Mol Biol Cell 17(10):4584\u20134591","journal-title":"Mol Biol Cell"},{"issue":"4","key":"3609_CR75","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4161\/pri.1.4.5058","volume":"1","author":"EG Rikhvanov","year":"2007","unstructured":"Rikhvanov EG, Romanova NV, Chernoff YO (2007) Chaperone effects on prion and nonprion aggregates. Prion 1(4):217\u2013222","journal-title":"Prion"},{"key":"3609_CR76","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fnmol.2018.00237","volume":"11","author":"S Rothe","year":"2018","unstructured":"Rothe S, Prakash A, Tyedmers J (2018) The insoluble protein deposit (IPOD) in yeast. Front Mol Neurosci 11:237","journal-title":"Front Mol Neurosci"},{"key":"3609_CR77","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1134\/S0026893308010160","volume":"42","author":"AA Rubel","year":"2008","unstructured":"Rubel AA, Saifitdinova AF, Lada AG, Nizhnikov AA, Inge-Vechtomov SG, Galkin AP (2008) Yeast chaperone Hsp104 controls gene expression at the posttranscriptional level. Mol Biol 42:110\u2013116","journal-title":"Mol Biol"},{"key":"3609_CR78","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00294-010-0314-2","volume":"56","author":"AF Saifitdinova","year":"2010","unstructured":"Saifitdinova AF, Nizhnikov AA, Lada AG, Rubel AA, Magomedova ZM, Ignatova VV, Inge-Vechtomov SG, Galkin AP (2010) [NSI+]: a novel non-Mendelian nonsense suppressor determinant in Saccharomyces cerevisiae. Curr Genet 56:467\u2013478","journal-title":"Curr Genet"},{"key":"3609_CR79","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","volume":"192","author":"DJ Selkoe","year":"2008","unstructured":"Selkoe DJ (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192:106\u2013113","journal-title":"Behav Brain Res"},{"key":"3609_CR80","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00203-003-0566-z","volume":"180","author":"KG Sharma","year":"2003","unstructured":"Sharma KG, Kaur R, Bachhawat AK (2003) The glutathione-mediated detoxification pathway in yeast: an analysis using the red pigment that accumulates in certain adenine biosynthetic mutants of yeasts reveals the involvement of novel genes. Arch Microbiol 180:108\u2013117","journal-title":"Arch Microbiol"},{"key":"3609_CR81","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41419-017-0130-4","volume":"9","author":"N Shvil","year":"2018","unstructured":"Shvil N, Banerjee V, Zoltsman G, Shani T, Kahn J, Abu-Hamad S, Papo N, Engel S, Bernhagen J, Israelson A (2018) MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALS. Cell Death Dis 9:107","journal-title":"Cell Death Dis"},{"key":"3609_CR82","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/13506129.2016.1257986","volume":"23","author":"JD Sipe","year":"2016","unstructured":"Sipe JD, Benson MD, Buxbaum JN, Ikeda SI, Merlini G, Saraiva MJM, Westermark P (2016) Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification. International Society of Amyloidosis 2016 Nomenclature Guidelines. Amyloid 23:209\u2013213","journal-title":"Amyloid"},{"key":"3609_CR83","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0006-291X(67)80096-2","volume":"27","author":"MN Smirnov","year":"1967","unstructured":"Smirnov MN, Smirnov VN, Budowsky EI, Inge-Vechtomov SG, Serebrjakov NG (1967) Red pigment of adenine-deficient yeast Saccharomyces cerevisiae. Biochem Biophys Res Commun 27:299\u2013304","journal-title":"Biochem Biophys Res Commun"},{"issue":"43","key":"3609_CR84","doi-asserted-by":"publisher","first-page":"15806","DOI":"10.1073\/pnas.0604035103","volume":"103","author":"Jeffrey F. Smith","year":"2006","unstructured":"Smith JF, Knowles TP, Dobson CM, MacPhee CE, Welland ME (2006) Characterization of the nanoscale properties of individual amyloid fibrils. Proc Natl Acad Sci, 103(43):15806-15811","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"3609_CR85","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1091\/mbc.e07-08-0827","volume":"19","author":"JH Soper","year":"2008","unstructured":"Soper JH, Roy S, Stieber A, Lee E, Wilson RB, Trojanowski JQ, Burd CG, Lee VMY (2008) \u03b1-Synuclein\u2013induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. Mol Biol Cell 19(3):1093\u201311103","journal-title":"Mol Biol Cell"},{"issue":"4","key":"3609_CR86","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1083\/jcb.201106037","volume":"195","author":"Sebastian Specht","year":"2011","unstructured":"Specht S, Miller SB, Mogk A, Bukau B (2011) Hsp42 is required for sequestration of protein aggregates into deposition sites in Saccharomyces cerevisiae. J Cell Biol 195:617\u2013629","journal-title":"Journal of Cell Biology"},{"key":"3609_CR87","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M (1997) \u03b1-synuclein in Lewy bodies. Nature 388:839\u2013840","journal-title":"Nature"},{"issue":"3","key":"3609_CR88","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","volume":"251","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous \u03b1-synuclein inclusions link multiple system atrophy with Parkinson\u2019s disease and dementia with Lewy bodies. Neurosci Let 251(3):205\u2013208","journal-title":"Neurosci Let"},{"key":"3609_CR89","doi-asserted-by":"crossref","unstructured":"Stefanis L (2012) \u03b1-synuclein in Parkinson\u2019s disease. Cold Spring HarbPerspect Med 2(2):a009399","DOI":"10.1101\/cshperspect.a009399"},{"issue":"1","key":"3609_CR90","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00441-018-2814-1","volume":"373","author":"JA Steiner","year":"2018","unstructured":"Steiner JA, Quansah E, Brundin P (2018) The concept of alpha-synuclein as a prion-like protein:ten years after. Cell Tissue Res 373(1):161\u2013173","journal-title":"Cell Tissue Res"},{"key":"3609_CR91","doi-asserted-by":"crossref","unstructured":"Tenreiro S, Eckermann K, Outeiro TF (2014a) Protein phosphorylation in neurodegeneration:friend or foe? Front Mol Neurosci 7(42):1\u2013121","DOI":"10.3389\/fnmol.2014.00042"},{"key":"3609_CR92","doi-asserted-by":"crossref","unstructured":"Tenreiro S, Franssens V, Winderickx J, Outeiro TF (2017) Yeast models of Parkinson\u2019s disease-associated molecular pathologies. Curr Opin Genet Dev 44:74\u201383","DOI":"10.1016\/j.gde.2017.01.013"},{"issue":"4","key":"3609_CR93","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/jnc.12271","volume":"127","author":"S Tenreiro","year":"2013","unstructured":"Tenreiro S, Munder MC, Alberti S, Outeiro TF (2013) Harnessing the power of yeast to unravel the molecular basis of neurodegeneration. J Neurochem 127(4):438\u2013452","journal-title":"J Neurochem"},{"issue":"8","key":"3609_CR94","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/j.1567-1364.2010.00649.x","volume":"10","author":"S Tenreiro","year":"2010","unstructured":"Tenreiro S, Outeiro TF (2010) Simple is good: yeast models of neurodegeneration. FEMS Yeast Res 10(8):970\u2013979","journal-title":"FEMS Yeast Res"},{"key":"3609_CR95","doi-asserted-by":"crossref","unstructured":"Tenreiro S, Reimao-Pinto MM, Antas P, Rino J, Wawrzycka D, Macedo D, Rosado-Ramos R, Amen T, Waiss M, Magalhaes F, Gomes A, Santos CN, Kaganovich D, Outeiro TF (2014b) Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson\u2019s disease. PLoS Genet 10(5):e1004302","DOI":"10.1371\/journal.pgen.1004302"},{"key":"3609_CR96","doi-asserted-by":"crossref","unstructured":"Tenreiro S, Rosado-Ramos R, Gerhardt E, Favretto F, Magalh\u00e3es F, Popova B, Outeiro TF (2016) Yeast reveals similar molecular mechanisms underlying alpha-and beta-synuclein toxicity. Hum Mol Genet 25(2):275\u2013290","DOI":"10.1093\/hmg\/ddv470"},{"key":"3609_CR97","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.2147\/IJN.S200490","volume":"14","author":"S Tiwari","year":"2019","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M (2019) Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine 14:5541\u20135554","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"3609_CR98","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/ana.21051","volume":"60","author":"M Townsend","year":"2006","unstructured":"Townsend M, Cleary JP, Mehta T, Hofmeister J, Lesne S, O\u2019Hare E, Walsh DM, Selkoe DJ (2006) Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers. Ann Neurol 60(6):668\u2013676","journal-title":"Ann Neurol"},{"key":"3609_CR99","doi-asserted-by":"crossref","unstructured":"Tuite MF (2019) Yeast models of neurodegenerative diseases. Prog Mol Biol Transl Sci 168:351\u2013379","DOI":"10.1016\/bs.pmbts.2019.07.001"},{"key":"3609_CR100","doi-asserted-by":"crossref","unstructured":"Villar-Piqu\u00e9 A, da Fonseca TL, Sant\u2019Anna R, Szeg\u00f6 \u00c9M, Fonseca-Ornelas L, Pinho R, Carija A, Gerhardt E, Masaracchia C, Abad GE, Rossetti G, Carloni P, Fern\u00e1ndez CO, Fogue lD, Milosevic I, Zweckstetter M, Ventura S, Outeiro TF (2016) Environmental and genetic factors support the dissociation between \u03b1-synuclein aggregation and toxicity. Proc Natl Acad Sci USA 113(42):E6506\u2013E6515","DOI":"10.1073\/pnas.1606791113"},{"issue":"4","key":"3609_CR101","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3233\/JPD-130216","volume":"3","author":"P Wales","year":"2013","unstructured":"Wales P, Pinho R, L\u00e1zaro DF, Outeiro TF (2013) Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration. J Parkins Dis 3(4):415\u2013459","journal-title":"J Parkins Dis"},{"key":"3609_CR102","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4161\/pri.1.2.4440","volume":"1","author":"Y Wang","year":"2007","unstructured":"Wang Y, Meriin AB, Costello CE, Sherman MY (2007) Characterization of proteins associated with polyglutamine aggregates: a novel approach towards isolation of aggregates from protein conformation disorders. Prion 1:128\u2013135","journal-title":"Prion"},{"issue":"2","key":"3609_CR103","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1096\/fj.08-117614","volume":"23","author":"Y Wang","year":"2009","unstructured":"Wang Y, Meriin AB, Zaarur N, Romanova NV, Chernoff YO, Costello CE, Sherman MY (2009) Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery. Faseb J 23(2):451\u2013463","journal-title":"Faseb J"},{"key":"3609_CR104","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1126\/science.7909170","volume":"264","author":"RB Wickner","year":"1994","unstructured":"Wickner RB (1994) [URE3] as an altered URE2 protein: evidence for a prion analog in S.cerevisiae. Science 264:566\u2013569","journal-title":"Science"},{"key":"3609_CR105","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4161\/pri.1.2.4664","volume":"1","author":"RB Wickner","year":"2007","unstructured":"Wickner RB, Edskes HK, Shewmaker F, Nakayashiki T, Engel A, McCann L, Kryndushkin D (2007) Yeast prions:evolution of the prion concept. Prion 1:94\u2013100","journal-title":"Prion"},{"key":"3609_CR106","doi-asserted-by":"crossref","unstructured":"Wickner RB, Kryndushkin D, Shewmaker F, McGlinchey R, Edskes HK (2018) Study of amyloids using yeast. In: Sigurdsson E, Calero M, Gasset M (eds) Amyloid proteins. Methods Mol Biol Volume 1779. Humana Press, New York, NY pp 313 \u2013 339","DOI":"10.1007\/978-1-4939-7816-8_19"},{"key":"3609_CR107","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/bies.20821","volume":"30","author":"RB Wickner","year":"2008","unstructured":"Wickner RB, Shewmaker F, Kryndushkin D, Edskes HK (2008) Protein inheritance (prions) based on parallel in-register \u03b2-sheet amyloid structures. BioEssays 30:955\u2013964","journal-title":"BioEssays"}],"container-title":["Cell and Tissue Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-022-03609-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00441-022-03609-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00441-022-03609-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T09:46:19Z","timestamp":1700300779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00441-022-03609-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["3609"],"URL":"https:\/\/doi.org\/10.1007\/s00441-022-03609-w","relation":{},"ISSN":["0302-766X","1432-0878"],"issn-type":[{"value":"0302-766X","type":"print"},{"value":"1432-0878","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,8]]},"assertion":[{"value":"6 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}